Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Pulmonary Hypertension, June 2022

Free Subscription


Abstracts

Retrieve all available abstracts of the following 176 articles:
HTML format


 

Single Articles

  1. YU S, Wang Y, Fan Y, Ma R, et al
    Pulmonary hypertension in patients with pneumoconiosis with progressive massive fibrosis.
    Occup Environ Med. 2022 Jun 2. pii: oemed-2021-108095.
    PubMed    
    Abstract available

  2. BUTLER O, Ju S, Hoernig S, Vogtlander K, et al
    Assessment for residual disease after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension.
    ERJ Open Res. 2022;8.
    PubMed    
    Abstract available

  3. ZHOU S, Shi S, Xie C, Chen G, et al
    Association between smoking and postoperative delirium in surgical patients with pulmonary hypertension: a secondary analysis of a cohort study.
    BMC Psychiatry. 2022;22:371.
    PubMed    
    Abstract available

  4. RICCARDI M, Pagnesi M, Sciatti E, Lombardi CM, et al
    Combined pre- and post-capillary pulmonary hypertension in left heart disease.
    Heart Fail Rev. 2022 Jun 1. pii: 10.1007/s10741-022-10251.
    PubMed    
    Abstract available

  5. WANG M, Hu Y, Guo B, Tang H, et al
    Simulation of Acute Pulmonary Hypertension in Beagle Dogs.
    Int Heart J. 2022;63:612-622.
    PubMed    
    Abstract available

  6. MATTHEWS CR, Madison M, Zhang C, Waters J, et al
    Trousseau Syndrome in a 25-Year-Old Woman with Occult Colon Malignancy, Lynch Syndrome, and Chronic Thromboembolic Pulmonary Hypertension.
    Tex Heart Inst J. 2022;49.
    PubMed    
    Abstract available

  7. MONG DA, Guillerman RP, Weinman JP
    Computed tomography evaluation of pediatric pulmonary hypertension.
    Pediatr Radiol. 2022 Jun 1. pii: 10.1007/s00247-022-05385.
    PubMed    
    Abstract available


  8. Erratum: Characteristics of Children with Bronchopulmonary Dysplasia with Prolonged and/or Later-Onset Pulmonary Hypertension.
    Ann Am Thorac Soc. 2022;19:1080.
    PubMed    


  9. NAKAMURA J, Tsujino I, Ohira H, Nakaya T, et al
    Various factors contribute to death in patients with different types of pulmonary hypertension: A retrospective pilot study from a single tertiary center.
    Respir Investig. 2022 May 26. pii: S2212-5345(22)00053.
    PubMed    
    Abstract available

  10. QIAN AM, Zhu W, Yang Y, Lu KY, et al
    [Early risk factors for death in neonates with persistent pulmonary hypertension of the newborn treated with inhaled nitric oxide].
    Zhongguo Dang Dai Er Ke Za Zhi. 2022;24:507-513.
    PubMed    
    Abstract available

  11. TEERAPUNCHAROEN K, Bag R
    Chronic Thromboembolic Pulmonary Hypertension.
    Lung. 2022 May 29. pii: 10.1007/s00408-022-00539.
    PubMed    
    Abstract available

  12. CUI L, Yuan T, Zeng Z, Liu D, et al
    Mechanistic and therapeutic perspectives of baicalin and baicalein on pulmonary hypertension: A comprehensive review.
    Biomed Pharmacother. 2022;151:113191.
    PubMed    
    Abstract available

  13. LI Q, Gu Y, Gao X, Guo X, et al
    Preparation of polyclonal antibody against phosphatidylethanolamine binding protein 1 recombinant protein and its functional verification in pulmonary hypertension syndrome in broilers.
    Int J Biol Macromol. 2022;213:19-26.
    PubMed    
    Abstract available

  14. MORIYAMA H, Endo J, Kataoka M, Shimanaka Y, et al
    Omega-3 fatty acid epoxides produced by PAF-AH2 in mast cells regulate pulmonary vascular remodeling.
    Nat Commun. 2022;13:3013.
    PubMed    
    Abstract available

  15. LEVY PT, Levin J, Leeman KT, Mullen MP, et al
    Diagnosis and management of pulmonary hypertension in infants with bronchopulmonary dysplasia.
    Semin Fetal Neonatal Med. 2022 May 26:101351. doi: 10.1016/j.siny.2022.101351.
    PubMed    
    Abstract available

  16. LI C, Zhu H, Zhang S, Meng F, et al
    Astragaloside IV ameliorates pulmonary vascular remodeling in hypoxia-induced pulmonary hypertension by restraining the T follicular helper cell response and expanding T follicular regulatory cell response.
    Phytomedicine. 2022;102:154171.
    PubMed    
    Abstract available

  17. KRZYZEWSKA A, Baranowska-Kuczko M, Jastrzab A, Kasacka I, et al
    Cannabidiol Improves Antioxidant Capacity and Reduces Inflammation in the Lungs of Rats with Monocrotaline-Induced Pulmonary Hypertension.
    Molecules. 2022;27.
    PubMed    
    Abstract available

  18. BUTANE L, Spilva-Ekerte L, Skride A, Smite D, et al
    Individually Tailored Remote Physiotherapy Program Improves Participation and Autonomy in Activities of Everyday Life along with Exercise Capacity, Self-Efficacy, and Low-Moderate Physical Activity in Patients with Pulmonary Arterial Hypertension: A R
    Medicina (Kaunas). 2022;58.
    PubMed    
    Abstract available

  19. UGAWA S, Akagi S, Ejiri K, Nakamura K, et al
    Quantification of Lung Perfusion Blood Volume in Dual-Energy Computed Tomography in Patients with Pulmonary Hypertension.
    Life (Basel). 2022;12.
    PubMed    
    Abstract available

  20. SCHNEIDER SR, Lichtblau M, Furian M, Mayer LC, et al
    Cardiorespiratory Adaptation to Short-Term Exposure to Altitude vs. Normobaric Hypoxia in Patients with Pulmonary Hypertension.
    J Clin Med. 2022;11.
    PubMed    
    Abstract available

  21. SLAWEK-SZMYT S, Araszkiewicz A, Jankiewicz S, Grygier M, et al
    Prognostic Value of Pulmonary Artery Pulsatility Index in Right Ventricle Failure-Related Mortality in Inoperable Chronic Thromboembolic Pulmonary Hypertension.
    J Clin Med. 2022;11.
    PubMed    
    Abstract available

  22. CROWE LA, Genecand L, Hachulla AL, Noble S, et al
    Non-Invasive Cardiac Output Determination Using Magnetic Resonance Imaging and Thermodilution in Pulmonary Hypertension.
    J Clin Med. 2022;11.
    PubMed    
    Abstract available

  23. VANDERPOOL RR, Gorelova A, Ma Y, Alhamaydeh M, et al
    Reversal of Right Ventricular Hypertrophy and Dysfunction by Prostacyclin in a Rat Model of Severe Pulmonary Arterial Hypertension.
    Int J Mol Sci. 2022;23.
    PubMed    
    Abstract available

  24. GALLEGO-ZAZO N, Cruz-Utrilla A, Del Cerro MJ, Ochoa Parra N, et al
    Description of Two New Cases of AQP1 Related Pulmonary Arterial Hypertension and Review of the Literature.
    Genes (Basel). 2022;13.
    PubMed    
    Abstract available

  25. THEOBALD V, Benjamin N, Seyfarth HJ, Halank M, et al
    Reduction of BMPR2 mRNA Expression in Peripheral Blood of Pulmonary Arterial Hypertension Patients: A Marker for Disease Severity?
    Genes (Basel). 2022;13.
    PubMed    
    Abstract available

  26. VRIGKOU E, Tsantes A, Konstantonis D, Rapti E, et al
    Platelet, Fibrinolytic and Other Coagulation Abnormalities in Newly-Diagnosed Patients with Chronic Thromboembolic Pulmonary Hypertension.
    Diagnostics (Basel). 2022;12.
    PubMed    
    Abstract available

  27. TRUONG L, Zheng YM, Wang YX
    The Potential Important Role of Mitochondrial Rieske Iron-Sulfur Protein as a Novel Therapeutic Target for Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease.
    Biomedicines. 2022;10.
    PubMed    
    Abstract available

  28. LAGGNER M, Oberndorfer F, Golabi B, Bauer J, et al
    EGR1 Is Implicated in Right Ventricular Cardiac Remodeling Associated with Pulmonary Hypertension.
    Biology (Basel). 2022;11.
    PubMed    
    Abstract available

  29. CHETAN C, Suryawanshi P, Patnaik S, Soni NB, et al
    Oral versus intravenous sildenafil for pulmonary hypertension in neonates: a randomized trial.
    BMC Pediatr. 2022;22:311.
    PubMed    
    Abstract available

  30. OGBOMO A, Tsang Y, Mallampati R, Panjabi S, et al
    The direct and indirect health care costs associated with pulmonary arterial hypertension among commercially insured patients in the United States.
    J Manag Care Spec Pharm. 2022;28:608-616.
    PubMed    
    Abstract available

  31. FANG X, He C, Ni X, Zhang T, et al
    A potential model of systemic sclerosis with pulmonary hypertension induced by monocrotaline plus bleomycin.
    Clin Exp Hypertens. 2022 May 27:1-7. doi: 10.1080/10641963.2022.2079665.
    PubMed    
    Abstract available

  32. JIANG C, Fang X, Fu W
    The Association of Body Mass Index With Mortality Among Pulmonary Hypertension Patients: A Systematic Review and Meta-Analysis of Cohort Studies.
    Front Public Health. 2022;10:761904.
    PubMed    
    Abstract available

  33. AZZO L, Ali YS, Vaqar S, Wang RR, et al
    Immunity and inflammation in pulmonary arterial hypertension: From pathophysiology mechanisms to treatment perspective.
    Pharmacol Res. 2022;180:106238.
    PubMed    
    Abstract available

  34. JERJES-SANCHEZ C, Glenn-Valdez H, Zayas N, Cueto-Robledo G, et al
    Riociguat in the Treatment of Pulmonary Arterial Hypertension.
    Arch Med Res. 2022;53:352-358.
    PubMed    
    Abstract available

  35. PHAM T, Tran K, Taberner AJ, Loiselle DS, et al
    Cross-bridge thermodynamics in pulmonary arterial hypertensive right-ventricular failure.
    J Appl Physiol (1985). 2022;132:1338-1349.
    PubMed    
    Abstract available

  36. ALVES-SILVA JM, Zuzarte M, Marques C, Viana S, et al
    1,8-Cineole ameliorates right ventricle dysfunction associated with pulmonary arterial hypertension by restoring connexin43 and mitochondrial homeostasis.
    Pharmacol Res. 2022;180:106151.
    PubMed    
    Abstract available

  37. IWAYA Y, Muneuchi J, Sugitani Y, Watanabe M, et al
    Pulmonary vascular resistance and compliance in pulmonary blood flow alterations in children with congenital heart disease.
    Heart Vessels. 2022;37:1283-1289.
    PubMed    
    Abstract available

  38. HAYAMA H, Moroi M, Adachi-Akahane S, Uejima T, et al
    A Novel Non-Invasive Method for Estimating Elevated Pulmonary Vascular Resistance Based on Echocardiographic Assessment of Pulmonary Artery Wave Reflection.
    Circ J. 2022;86:947-955.
    PubMed    
    Abstract available

  39. COLALILLO A, Grimaldi MC, Vaiarello V, Pellicano C, et al
    In systemic sclerosis, the TAPSE/sPAP ratio can be used in addition to the DETECT algorithm for pulmonary arterial hypertension diagnosis.
    Rheumatology (Oxford). 2022;61:2450-2456.
    PubMed    
    Abstract available

  40. ZHAO C, Hu L, He X, Li L, et al
    TPN171H alleviates pulmonary hypertension via inhibiting inflammation in hypoxia and monocrotaline-induced rats.
    Vascul Pharmacol. 2022 Jun 6:107017. doi: 10.1016/j.vph.2022.107017.
    PubMed    
    Abstract available

  41. LUI JK, Gillmeyer KR, Sangani RA, Smyth RJ, et al
    A Multimodal Prediction Model for Diagnosing Pulmonary Hypertension in Systemic Sclerosis.
    Arthritis Care Res (Hoboken). 2022 Jun 9. doi: 10.1002/acr.24969.
    PubMed    
    Abstract available

  42. DADLANI A, Eiswerth M, Bosch A, Sharpe T, et al
    Pulmonary Hypertension as a Rare Complication After Orthotopic Liver Transplant in a Patient With Non-alcoholic Steatohepatitis (NASH) Cirrhosis Complicated by Hepatopulmonary Syndrome.
    Cureus. 2022;14:e24740.
    PubMed    
    Abstract available

  43. CHELLADURAI P, Kuenne C, Bourgeois A, Gunther S, et al
    Epigenetic reactivation of transcriptional programs orchestrating fetal lung development in human pulmonary hypertension.
    Sci Transl Med. 2022;14:eabe5407.
    PubMed    
    Abstract available

  44. CHEN B, Jin Y, Pool CM, Liu Y, et al
    Hypoxic pulmonary endothelial cells release epidermal growth factor leading to vascular smooth muscle cell arginase-2 expression and proliferation.
    Physiol Rep. 2022;10:e15342.
    PubMed    
    Abstract available

  45. ZHANG X, Liu S, Sun Y, Li G, et al
    [Tanshinone IIA alleviates monocrotaline-induced pulmonary hypertension in rats through the PI3K/Akt-eNOS signaling pathway].
    Nan Fang Yi Ke Da Xue Xue Bao. 2022;42:718-723.
    PubMed    
    Abstract available

  46. HONORE PM, Redant S, Djimafo P, Blackman S, et al
    Endarterectomy treatment for patients suffering from a new episode of pulmonary embolism, after screening for chronic thromboembolic pulmonary hypertension.
    Crit Care. 2022;26:165.
    PubMed    


  47. DHOBLE S, Patravale V
    SIRT 1 Activator Loaded Inhaled Antiangiogenic Liposomal Formulation Development for Pulmonary Hypertension.
    AAPS PharmSciTech. 2022;23:158.
    PubMed    
    Abstract available

  48. TSENG V, Collum S, Allawzi A, Crotty K, et al
    3'UTR shortening of HAS2 promotes hyaluronan hyper-synthesis and bioenergetic dysfunction in pulmonary hypertension.
    Matrix Biol. 2022 Jun 4. pii: S0945-053X(22)00075.
    PubMed    
    Abstract available

  49. PATEL JK, Ramkishun CA, Haw A, Mehta K, et al
    Association of Pulmonary Hypertension with Survival and Neurologic Outcomes in Adults with In-Hospital Cardiac Arrest.
    Resuscitation. 2022 Jun 4. pii: S0300-9572(22)00171.
    PubMed    
    Abstract available

  50. PETHO A, Szebeni J
    Pulmonary hypertension in a hemodialysis porcine model: possible unforeseen causes?
    Ren Fail. 2022;44:693.
    PubMed    


  51. ANDERSEN MO, Diederichsen S, Svendsend JH, Carlsen J, et al
    Continuous cardiac monitoring in a patient with terminal pulmonary hypertension and eventual bilateral lung transplantation.
    BMJ Case Rep. 2022;15.
    PubMed    
    Abstract available

  52. TU J, Jin J, Chen X, Sun L, et al
    Altered Cellular Immunity and Differentially Expressed Immune-Related Genes in Patients With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.
    Front Immunol. 2022;13:868983.
    PubMed    
    Abstract available

  53. ALBABA I, Medarov BI
    A case of severe cancer-related pulmonary hypertension; An unexpected resolution.
    Respir Med Case Rep. 2022;38:101671.
    PubMed    
    Abstract available

  54. HAYASHI H, Oda S, Emoto T, Kidoh M, et al
    Myocardial extracellular volume quantification by cardiac CT in pulmonary hypertension: Comparison with cardiac MRI.
    Eur J Radiol. 2022;153:110386.
    PubMed    
    Abstract available

  55. STAPEL JR, Speed JS, Clemmer JS
    Endothelin antagonism reduces hemoglobin A1c in patients with pulmonary hypertension.
    Can J Physiol Pharmacol. 2022 Jun 3. doi: 10.1139/cjpp-2022-0132.
    PubMed    
    Abstract available

  56. XIAO XH, Luo FM, Wang EL, Fu MY, et al
    Magnolol alleviates hypoxia-induced pulmonary vascular remodeling through inhibition of phenotypic transformation in pulmonary arterial smooth muscle cells.
    Biomed Pharmacother. 2022;150:113060.
    PubMed    
    Abstract available

  57. XU J, Zhong Y, Wang Z
    Decrease in Tripartite Motif Containing 24 suppresses hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells via the AKT/mammalian target of rapamycin complex 1 pathway.
    Bioengineered. 2022;13:13596-13606.
    PubMed    
    Abstract available

  58. ZANI A, Chung WK, Deprest J, Harting MT, et al
    Congenital diaphragmatic hernia.
    Nat Rev Dis Primers. 2022;8:37.
    PubMed    
    Abstract available

  59. KHANGOORA VS, King CS, Shlobin OA
    Managing pulmonary arterial hypertension: how to select and facilitate successful transplantation.
    Curr Opin Organ Transplant. 2022;27:169-176.
    PubMed    
    Abstract available

  60. MONOSILIO S, Filomena D, Cimino S, Birtolo LI, et al
    Prognostic value of systemic inflammatory response syndrome after transcatheter aortic valve implantation.
    J Cardiovasc Med (Hagerstown). 2022;23:394-398.
    PubMed    
    Abstract available

  61. SCHULER KP, Hemnes AR, Annis J, Farber-Eger E, et al
    An algorithm to identify cases of pulmonary arterial hypertension from the electronic medical record.
    Respir Res. 2022;23:138.
    PubMed    
    Abstract available

  62. ALQARNI AA, Brand OJ, Pasini A, Alahmari M, et al
    Imbalanced prostanoid release mediates cigarette smoke-induced human pulmonary artery cell proliferation.
    Respir Res. 2022;23:136.
    PubMed    
    Abstract available

  63. AZZO L, Ali YS, Vaqar S, Dhoble S, et al
    Comprehensive review on novel targets and emerging therapeutic modalities for pulmonary arterial Hypertension.
    Int J Pharm. 2022;621:121792.
    PubMed    
    Abstract available

  64. ZHAO H, Yan Y, Liu Y, Long L, et al
    Bedside critical ultrasound as a key to the diagnosis of obstructive atelectasis complicated with acute cor pulmonale and differentiation from pulmonary embolism: A case report.
    J Clin Ultrasound. 2022;50:611-617.
    PubMed    
    Abstract available

  65. USTA DY, Timur B, Teksin ZS
    Formulation development, optimization by Box-Behnken design, characterization, in vitro, ex-vivo, and in vivo evaluation of bosentan-loaded self-nanoemulsifying drug delivery system: A novel alternative dosage form for pulmonary arterial hypertension
    Eur J Pharm Sci. 2022;174:106159.
    PubMed    
    Abstract available

  66. VRAKA A, Yerly P, Aubert JD
    Comparison of Risk Stratification Scores in Pulmonary Arterial Hypertension: A Monocentric Retrospective Study at Lausanne University Hospital.
    Respiration. 2022;101:565-576.
    PubMed    
    Abstract available

  67. MIN J, Appleby DH, McClelland RL, Minhas J, et al
    Secular and Regional Trends among Pulmonary Arterial Hypertension Clinical Trial Participants.
    Ann Am Thorac Soc. 2022;19:952-961.
    PubMed    
    Abstract available

  68. SUDA T, Zoshima T, Ito K, Mizushima I, et al
    Successful Early Immunosuppressive Therapy for Pulmonary Arterial Hypertension Due to Takayasu arteritis: Two Case Reports and a Review of Similar Case Reports in the English Literature.
    Intern Med. 2022;61:1767-1774.
    PubMed    
    Abstract available

  69. PFANNMUELLER B, Budde LM, Noack T, Marin-Cuartas M, et al
    Is the pulmonary pressure directly correlated with the operative risk in patients with isolated tricuspid valve surgery?
    J Cardiovasc Surg (Torino). 2022;63:376-381.
    PubMed    
    Abstract available

  70. XIE Y, Liu N, Xiao Z, Yang F, et al
    The progress of pulmonary artery denervation.
    Cardiol J. 2022;29:381-387.
    PubMed    
    Abstract available

  71. WANG L, Zhang Z, Zhao Z, Yan C, et al
    (68)Ga-FAPI right heart uptake in a patient with idiopathic pulmonary arterial hypertension.
    J Nucl Cardiol. 2022;29:1475-1477.
    PubMed    


  72. SUNAGAWA G, Kehara H, Mangukia C, Brann S, et al
    Single Lung Transplant Remains a Viable Option for Patients With Severe Secondary Pulmonary Hypertension.
    Transplantation. 2022 Jun 6. pii: 00007890-990000000-00069.
    PubMed    
    Abstract available

  73. EBERLEIN M, Reed RM
    A New Look at an Old Problem: Is Single Lung Transplantation an Option in Candidates With Significant Secondary Pulmonary Hypertension?
    Transplantation. 2022 Jun 6. pii: 00007890-990000000-00070.
    PubMed    


  74. ALENCAR AKN
    Should we Consider the Stimulation of Soluble Guanylyl Cyclase as Beneficial for Treating Pre-Capillary Pulmonary Hypertension?
    Arq Bras Cardiol. 2022;118:1067-1068.
    PubMed    


  75. YASAR S, Koksal O, Eski S, Asil S, et al
    Incidentally Diagnosed Double Inferior Vena Cava While Being Investigated for Pulmonary Hypertension.
    Anatol J Cardiol. 2022;26:E8-E9.
    PubMed    


  76. BRIEGER D, Rye EE, Hungerford SL
    Editorial for "Risk Stratification and Outcomes in Patients with Pulmonary Hypertension: Insights into Right Ventricular Strain by MRI Feature-Tracking".
    J Magn Reson Imaging. 2022 Jun 14. doi: 10.1002/jmri.28289.
    PubMed    


  77. JOSHI S, Quinones Cardona V, Menkiti OR
    Use of vasopressin in persistent pulmonary hypertension of the newborn: A case series.
    SAGE Open Med Case Rep. 2022;10:2050313X221102289.
    PubMed    
    Abstract available

  78. CHEN J, Ding S, Zhang C, Li R, et al
    Clinical value of echocardiography in evaluating hemodynamics and right ventricular function in patients with chronic thromboembolic pulmonary hypertension after balloon pulmonary angioplasty.
    J Thorac Dis. 2022;14:1401-1410.
    PubMed    
    Abstract available

  79. COOKSON MW, Abman SH, Kinsella JP, Mandell EW, et al
    Pulmonary vasodilator strategies in neonates with acute hypoxemic respiratory failure and pulmonary hypertension.
    Semin Fetal Neonatal Med. 2022 Jun 3:101367. doi: 10.1016/j.siny.2022.101367.
    PubMed    
    Abstract available

  80. PEREZ JM, Melvin PR, Berry JG, Mullen MP, et al
    Outcomes for Children With Pulmonary Hypertension Undergoing Tracheostomy Placement: A Multi-Institutional Analysis.
    Pediatr Crit Care Med. 2022 Jun 10. pii: 00130478-990000000-00045.
    PubMed    
    Abstract available

  81. HONG C, Lu J, Chen R, Liu H, et al
    CXCL10 levels in diagnosis and improved hemodynamics in patients with chronic thromboembolic pulmonary hypertension undergoing balloon pulmonary angioplasty.
    Pulm Circ. 2022;12:e12091.
    PubMed    
    Abstract available

  82. ARVANITAKI A, Vrana E, Boutsikou M, Anthi A, et al
    The impact of cardiovascular comorbidities associated with risk for left heart disease on idiopathic pulmonary arterial hypertension: Data from the Hellenic Pulmonary Hypertension Registry (HOPE).
    Pulm Circ. 2022;12:e12086.
    PubMed    
    Abstract available

  83. AKATLI AN, Ulutas H, Turkmen Samdanci E, Celik MR, et al
    Bronchiectasis: Retrospective Analysis of Clinical and Pathological Findings in a Tertiary-Care Hospital.
    Int J Clin Pract. 2022;2022:8773204.
    PubMed    
    Abstract available

  84. LI Y, Qiu H, Zhao Q, He J, et al
    The Different Effects of Direct Bilirubin on Portopulmonary Hypertension and Idiopathic Pulmonary Arterial Hypertension.
    Int J Clin Pract. 2022;2022:7021178.
    PubMed    
    Abstract available

  85. NKOKE C, Makoge C
    Prolapsing left atrial mass causing severe pulmonary hypertension in a new cardiac service in a rural hospital in Cameroon: a case report.
    Pan Afr Med J. 2022;41:196.
    PubMed    
    Abstract available

  86. SU D, Huang Y, Liu D, Huang Y, et al
    Bioinformatic analysis of dysregulated circular RNAs in pediatric pulmonary hypertension linked congenital heart disease.
    Transl Pediatr. 2022;11:715-727.
    PubMed    
    Abstract available

  87. AGNIHOTRI V, Agrawal Y, Goyal S, Sharma C, et al
    An Update on Advancements and Challenges in Inhalational Drug Delivery for Pulmonary Arterial Hypertension.
    Molecules. 2022;27.
    PubMed    
    Abstract available

  88. KIPFMUELLER F, Akkas S, Pugnaloni F, Bo B, et al
    Echocardiographic Assessment of Pulmonary Hypertension in Neonates with Congenital Diaphragmatic Hernia Using Pulmonary Artery Flow Characteristics.
    J Clin Med. 2022;11.
    PubMed    
    Abstract available

  89. FLORES K, Siques P, Brito J, Arribas SM, et al
    AMPK and the Challenge of Treating Hypoxic Pulmonary Hypertension.
    Int J Mol Sci. 2022;23.
    PubMed    
    Abstract available

  90. PENG Q, Shan D, Cui K, Li K, et al
    The Role of Endothelial-to-Mesenchymal Transition in Cardiovascular Disease.
    Cells. 2022;11.
    PubMed    
    Abstract available

  91. SUZUKI S, Asano R, Aoki T, Nakayama S, et al
    Prognostic impact of follow-up pulmonary vascular resistance in pulmonary arterial hypertension.
    Open Heart. 2022;9.
    PubMed    
    Abstract available

  92. JAIN PP, Hosokawa S, Babicheva A, Zhao T, et al
    In Vivo and Ex Vivo Experimental Approach for Studying Functional Role of Notch in Pulmonary Vascular Disease.
    Methods Mol Biol. 2022;2472:209-220.
    PubMed    
    Abstract available

  93. DE CARVALHO NUNES G, Grenier K, Maedler Kron C, Kitzler T, et al
    Pulmonary lymphangiectasia in myotubular myopathy: a novel unrecognized association?
    Neuromuscul Disord. 2022;32:512-515.
    PubMed    
    Abstract available

  94. BERGER MM, Sareban M, Schiefer LM, Swenson KE, et al
    Effects of acetazolamide on pulmonary artery pressure and prevention of high-altitude pulmonary edema after rapid active ascent to 4,559 m.
    J Appl Physiol (1985). 2022;132:1361-1369.
    PubMed    
    Abstract available

  95. BUXTON RB, Prisk GK, Hopkins SR
    A novel nonlinear analysis of blood flow dynamics applied to the human lung.
    J Appl Physiol (1985). 2022;132:1546-1559.
    PubMed    
    Abstract available

  96. HASHIMOTO R, Gupte SA
    G6PD is a critical enabler of hypoxia-induced accumulation of macrophages and platelets in mice lungs and contributor to lung inflammation.
    Vascul Pharmacol. 2022;144:106976.
    PubMed    
    Abstract available

  97. BADAGLIACCA R, Mercurio V, Romeo E, Correale M, et al
    Beta-blockers in pulmonary arterial hypertension: Time for a second thought?
    Vascul Pharmacol. 2022;144:106974.
    PubMed    
    Abstract available

  98. GAUTHIER-LOISELLE M, Tsang Y, Lefebvre P, Agron P, et al
    Development and evaluation of a predictive algorithm for unsatisfactory response among patients with pulmonary arterial hypertension using health insurance claims data.
    Curr Med Res Opin. 2022;38:1019-1030.
    PubMed    
    Abstract available

  99. SAFAI ZADEH E, Dietrich CF, Kmoth L, Trenker C, et al
    Peripheral Pulmonary Lesions in Confirmed Pulmonary Arterial Embolism: Follow-up Study of B-Mode Ultrasound and of Perfusion Patterns Using Contrast-Enhanced Ultrasound (CEUS).
    J Ultrasound Med. 2022;41:1713-1721.
    PubMed    
    Abstract available

  100. CARAVACA PEREZ P, Aurtenetxe Perez A, Escribano Subias P
    Giant pulmonary artery aneurysm in pulmonary arterial hypertension.
    Arch Bronconeumol. 2021;57:541.
    PubMed    


  101. HU Y, Jin L, Pan Y, Zou J, et al
    Apela gene therapy alleviates pulmonary hypertension in rats.
    FASEB J. 2022;36:e22431.
    PubMed    
    Abstract available

  102. APPENZELLER P, Gautschi F, Muller J, Lichtblau M, et al
    Prediction of maximal oxygen uptake from 6-min walk test in pulmonary hypertension.
    ERJ Open Res. 2022;8.
    PubMed    
    Abstract available

  103. KIMURO K, Hosokawa K, Abe K, Masaki K, et al
    Beneficial Effects of Pulmonary Vasodilators on Pre-Capillary Pulmonary Hypertension in Patients with Chronic Kidney Disease on Hemodialysis.
    Life (Basel). 2022;12.
    PubMed    
    Abstract available

  104. RODRIGUEZ-RAMALLO H, Baez-Gutierrez N, Otero-Candelera R, Martin LA, et al
    Subgroup Analysis in Pulmonary Hypertension-Specific Therapy Clinical Trials: A Systematic Review.
    J Pers Med. 2022;12.
    PubMed    
    Abstract available

  105. LEE JH, Park JH, Hwang IC, Park JJ, et al
    Decreased Peak Left Atrial Longitudinal Strain Is Associated with Persistent Pulmonary Hypertension Associated with Left Heart Disease.
    J Clin Med. 2022;11.
    PubMed    
    Abstract available

  106. DENG L, Han X, Wang Z, Nie X, et al
    The Landscape of Noncoding RNA in Pulmonary Hypertension.
    Biomolecules. 2022;12.
    PubMed    
    Abstract available

  107. SUN Y, Tang C, Jin H, Du J, et al
    Implications of Hydrogen Sulfide in Development of Pulmonary Hypertension.
    Biomolecules. 2022;12.
    PubMed    
    Abstract available

  108. JI D, Qiao Y, Guan X, Zhang T, et al
    Serum miR-204 and miR-451 Expression and Diagnostic Value in Patients with Pulmonary Artery Hypertension Triggered by Congenital Heart Disease.
    Comput Math Methods Med. 2022;2022:9430708.
    PubMed    
    Abstract available

  109. BENALDO FA, Araya-Quijada C, Ebensperger G, Herrera EA, et al
    Cinaciguat (BAY-582667) Modifies Cardiopulmonary and Systemic Circulation in Chronically Hypoxic and Pulmonary Hypertensive Neonatal Lambs in the Alto Andino.
    Front Physiol. 2022;13:864010.
    PubMed    
    Abstract available

  110. TABUCHI I, Ogawa A, Shigetoshi M, Shimokawahara H, et al
    Low incidence of restenosis after successful balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension.
    Cardiovasc Interv Ther. 2022 Jun 22. pii: 10.1007/s12928-022-00866.
    PubMed    
    Abstract available

  111. FLORENTIN J, Zhao J, Tai YY, Sun W, et al
    Loss of Amphiregulin drives inflammation and endothelial apoptosis in pulmonary hypertension.
    Life Sci Alliance. 2022;5.
    PubMed    
    Abstract available

  112. DE SMALEN PP, Stoutjesdijk MJ
    Vascular anomaly diagnosis by central venous catheter misplacement: a case report.
    J Med Case Rep. 2022;16:259.
    PubMed    
    Abstract available

  113. WANG D, Huang S, Xu G, Wu S, et al
    Abnormal Liver Function Tests Were Related to Short- and Long-Term Prognosis in Critically Ill Patients With Primary Pulmonary Hypertension.
    Front Cardiovasc Med. 2022;9:897040.
    PubMed    
    Abstract available

  114. LIN K, Sarnari R, Pathrose A, Gordon DZ, et al
    Cine magnetic resonance imaging detects shorter cardiac rest periods in postcapillary pulmonary hypertension.
    Eur Heart J Cardiovasc Imaging. 2022 Jun 20. pii: 6611497.
    PubMed    
    Abstract available

  115. MORE K, Soni R, Gupta S
    The role of bedside functional echocardiography in the assessment and management of pulmonary hypertension.
    Semin Fetal Neonatal Med. 2022 Jun 14:101366. doi: 10.1016/j.siny.2022.101366.
    PubMed    
    Abstract available

  116. MURTA MS, Duarte RLM, Waetge D, Gozal D, et al
    Sleep-Disordered Breathing in Adults with Precapillary Pulmonary Hypertension: Prevalence and Predictors of Nocturnal Hypoxemia.
    Lung. 2022 Jun 18. pii: 10.1007/s00408-022-00547.
    PubMed    
    Abstract available

  117. MUKHERJEE D, Rana U, Kriegel AJ, Liu P, et al
    Fetal pulmonary hypertension: dysregulated microRNA-34c-Notch1 axis contributes to impaired angiogenesis in an ovine model.
    Pediatr Res. 2022 Jun 18. pii: 10.1038/s41390-022-02151.
    PubMed    
    Abstract available

  118. ZHOU D, Li X, Yin G, Li S, et al
    Risk Stratification and Outcomes in Patients With Pulmonary Hypertension: Insights into Right Ventricular Strain by MRI Feature tracking.
    J Magn Reson Imaging. 2022 Jun 17. doi: 10.1002/jmri.28291.
    PubMed    
    Abstract available

  119. HU X, Wang Q, Zhao H, Wu W, et al
    Role of miR-21-5p/FilGAP axis in estradiol alleviating the progression of monocrotaline-induced pulmonary hypertension.
    Animal Model Exp Med. 2022 Jun 17. doi: 10.1002/ame2.12253.
    PubMed    
    Abstract available

  120. LIU Y, Shi JZ, Jiang R, Liu SF, et al
    Regulatory T Cell-Related Gene Indicators in Pulmonary Hypertension.
    Front Pharmacol. 2022;13:908783.
    PubMed    
    Abstract available

  121. RAO S, Daines B, Hosseini O, Test V, et al
    The Utility of Brain Natriuretic Peptide in Patients Undergoing an Initial Evaluation for Pulmonary Hypertension.
    J Community Hosp Intern Med Perspect. 2022;12:48-52.
    PubMed    
    Abstract available

  122. ZHANG L, Liu Y, Zhao S, Wang Z, et al
    The Incidence and Prevalence of Pulmonary Hypertension in the COPD Population: A Systematic Review and Meta-Analysis.
    Int J Chron Obstruct Pulmon Dis. 2022;17:1365-1379.
    PubMed    
    Abstract available

  123. TANG S, Liu Y, Liu B
    Integrated bioinformatics analysis reveals marker genes and immune infiltration for pulmonary arterial hypertension.
    Sci Rep. 2022;12:10154.
    PubMed    
    Abstract available

  124. WU XH, Chen ZR, He ZY, Dong Y, et al
    [Gene expression signature analysis of peripheral blood mononuclear cells from patients with for high altitude pulmonary hypertension and value for potential drug selection].
    Zhonghua Xin Xue Guan Bing Za Zhi. 2022;50:577-584.
    PubMed    
    Abstract available

  125. HYDER SN, Chatterjee S, Aggarwal V
    Percutaneous Treatments for Pulmonary Hypertension: Reviewing the Growing Procedural Role for Interventional Cardiology.
    Interv Cardiol Clin. 2022;11:293-305.
    PubMed    
    Abstract available

  126. SAGRIS M, Bakoyiannis C
    Venous Thromboembolism and Chronic Thromboembolic Pulmonary Hypertension: Novel Clinical Insights.
    Curr Pharm Des. 2022;28:769-770.
    PubMed    


  127. QIN Y, Qiao Y, Wang D, Li L, et al
    Target Nuclear Factor Erythroid 2-Related Factor 2 in Pulmonary Hypertension: Molecular Insight into Application.
    Oxid Med Cell Longev. 2022;2022:7845503.
    PubMed    
    Abstract available

  128. JIN T, Lu H, Zhang Z, Wang Y, et al
    CYP2S1 gene methylation among High-altitude pulmonary edema.
    Gene. 2022;834:146590.
    PubMed    
    Abstract available

  129. HENDRIKS PM, van de Groep LD, Veen KM, van Thor MCJ, et al
    Prognostic value of brain natriuretic peptides in patients with pulmonary arterial hypertension: a systematic review and meta-analysis.
    Am Heart J. 2022 May 6. pii: S0002-8703(22)00093.
    PubMed    
    Abstract available

  130. SANNA L, Todea A
    Risk assessment tools for survival prognosis: An era of new surrogacy endpoints for clinical outcome measurement in pulmonary arterial hypertension clinical trials?
    Respir Med Res. 2022;81:100893.
    PubMed    
    Abstract available

  131. KELLY TD, Meier M, Weinman JP, Ivy D, et al
    High-Altitude Pulmonary Edema in Colorado Children: A Cross-Sectional Survey and Retrospective Review.
    High Alt Med Biol. 2022;23:119-124.
    PubMed    
    Abstract available

  132. QIU C, Li QW, Zhang L, Liu XL, et al
    X-linked osteogenesis imperfecta accompanied by patent ductus arteriosus: a case with a novel splice variant in PLS3.
    World J Pediatr. 2022;18:515-519.
    PubMed    


  133. QUAN R, Zhang G, Yu Z, Zhang C, et al
    Characteristics, goal-oriented treatments and survival of pulmonary arterial hypertension in China: Insights from a national multicentre prospective registry.
    Respirology. 2022;27:517-528.
    PubMed    
    Abstract available

  134. LEFEBVRE B, Kyheng M, Giordano J, Lamblin N, et al
    Dual-energy CT lung perfusion characteristics in pulmonary arterial hypertension (PAH) and pulmonary veno-occlusive disease and/or pulmonary capillary hemangiomatosis (PVOD/PCH): preliminary experience in 63 patients.
    Eur Radiol. 2022;32:4574-4586.
    PubMed    
    Abstract available

  135. LUNA-LOPEZ R, Ruiz Martin A, Escribano Subias P
    Pulmonary arterial hypertension.
    Med Clin (Barc). 2022;158:622-629.
    PubMed    
    Abstract available

  136. SALVADOR ML, Rodriguez-Padial L, Soto Abanades C, Cruz Utrilla A, et al
    Management and prognosis of HIV-associated pulmonary arterial hypertension: 20 Years of evidence from the REHAP registry.
    J Intern Med. 2022;292:116-126.
    PubMed    
    Abstract available

  137. SMITH A, Bussmann N, Breatnach C, Levy PT, et al
    The Relationship Between Postnatal Pulmonary Arterial Pressure and Altered Diastolic Function in Neonates with Down Syndrome.
    J Pediatr. 2022 Feb 14. pii: S0022-3476(22)00113.
    PubMed    
    Abstract available

  138. HADDAD F, Ataam JA, Amsallem M, Cauwenberghs N, et al
    Insulin Growth Factor Phenotypes in Heart Failure with Preserved Ejection Fraction, an INSPIRE Registry and CATHGEN Study: IGF axis in HFpEF.
    J Card Fail. 2021 Dec 31. pii: S1071-9164(21)00526.
    PubMed    
    Abstract available

  139. NGUYEN-THU H, Ohyama Y, Taketomi-Takahashi A, Nguyen-Cong T, et al
    Pulmonary Artery Diameter (PAD) and the Pulmonary Artery to Aorta Ratio (PAD/AAD) as Assessed by Non-contrast Cardiac CT: The Association with Left Ventricular (LV) Remodeling and the LV Function.
    Intern Med. 2022;61:1809-1815.
    PubMed    
    Abstract available

  140. BHOSLE KN, Paul S, Nagre SW
    Proposition of quantitative parameters for pre- and early post-operative assessment in pulmonary thromboendarterectomy - An Indian prospective study.
    Asian Cardiovasc Thorac Ann. 2022;30:549-554.
    PubMed    
    Abstract available

  141. SHETTY V, Punnen J, Natarajan P, Orathi S, et al
    Experience with pulmonary endarterectomy: Lessons learned across 17 years.
    Asian Cardiovasc Thorac Ann. 2022;30:532-539.
    PubMed    
    Abstract available

  142. JELLIS CL, Park MM, Abidov A, Borlaug BA, et al
    Comprehensive echocardiographic evaluation of the right heart in patients with pulmonary vascular diseases: the PVDOMICS experience.
    Eur Heart J Cardiovasc Imaging. 2022;23:958-969.
    PubMed    
    Abstract available

  143. JUNG YH, Ren X, Suffredini G, Dodd-O JM, et al
    Right ventricular diastolic dysfunction and failure: a review.
    Heart Fail Rev. 2022;27:1077-1090.
    PubMed    
    Abstract available

  144. MELIOTA G, Vairo U, Ficarella R, Milella L, et al
    Cardiovascular, Brain, and Lung Involvement in a Newborn With a Novel FLNA Mutation: A Case Report and Literature Review.
    Adv Neonatal Care. 2022;22:125-131.
    PubMed    
    Abstract available

  145. WILLIAMS EE, Nanjundappa M, Babla K, Wong J, et al
    Pericardial effusion and pulmonary vein stenosis in severe bronchopulmonary dysplasia.
    Arch Dis Child Fetal Neonatal Ed. 2022;107:447.
    PubMed    


  146. JOGA S, Bansal A, Talwar V, Bothra SJ, et al
    Spontaneous pulmonary arterial embolization: A rare complication of the silicon-based peripherally inserted central venous catheter (PICC).
    J Vasc Access. 2022;23:471-473.
    PubMed    
    Abstract available

  147. BUTCHER SC, Feloukidis C, Kamperidis V, Yedidya I, et al
    Right Ventricular Myocardial Work Characterization in Patients With Pulmonary Hypertension and Relation to Invasive Hemodynamic Parameters and Outcomes.
    Am J Cardiol. 2022 Jun 9. pii: S0002-9149(22)00535.
    PubMed    
    Abstract available

  148. KASSIS N, Layoun H, Goyal A, Dong T, et al
    Mechanistic Insights into Tricuspid Regurgitation Secondary to Pulmonary Arterial Hypertension.
    Am J Cardiol. 2022 May 18. pii: S0002-9149(22)00407.
    PubMed    
    Abstract available

  149. PRZEBINDA AS, El Haj Chehade A, Farooqui SM, Youness HA, et al
    Assessment of Pulmonary Vascular Disease: Pulmonary Vascular Resistance, Exercise Hemodynamics, and Ventriculovascular Coupling.
    Am J Respir Crit Care Med. 2022;205:1349.
    PubMed    


  150. PROVENCHER S, Potus F, Blais-Lecours P, Bernard S, et al
    BET Protein Inhibition for Pulmonary Arterial Hypertension: A Pilot Clinical Trial.
    Am J Respir Crit Care Med. 2022;205:1357-1360.
    PubMed    


  151. SOBRANO FAIS R, Lahm T
    Misbehaving Guests in the Right Ventricle: Macrophage NLRP3 Activation in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2022 Jun 15. doi: 10.1164/rccm.202205-0977.
    PubMed    


  152. ABMAN SH, Mullen MP
    Of Registries and Disease Classification: Unmasking the Challenges of Pediatric Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2022 Jun 23. doi: 10.1164/rccm.202206-1180.
    PubMed    


  153. OKAZAKI A, Kinuya K, Fujimoto M
    Diffuse Decreased Blood Flow in the Right Lung: Mitral Regurgitation-Induced Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2022 Jun 23. doi: 10.1164/rccm.202110-2339.
    PubMed    


  154. SIMPSON CE, Hassoun PM
    Promises and Pitfalls of Multiomics Approaches to Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2022;205:1377-1379.
    PubMed    


  155. HARBAUM L, Rhodes CJ, Wharton J, Lawrie A, et al
    Mining the Plasma Proteome for Insights into the Molecular Pathology of Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2022;205:1449-1460.
    PubMed    
    Abstract available

  156. SCHWIENING M, Swietlik EM, Pandya D, Burling K, et al
    Different Cytokine Patterns in BMPR2-Mutation-Positive Patients and Patients With Pulmonary Arterial Hypertension Without Mutations and Their Influence on Survival.
    Chest. 2022;161:1651-1656.
    PubMed    


  157. TRAVIN N, Dalinin V, Salimov D
    Thoracic bilateral sympathectomy as a new method of pulmonary arterial hypertension treatment: gaps of evidence.
    Eur J Cardiothorac Surg. 2022;61:1346-1347.
    PubMed    


  158. BENATTIA A, Bugnet E, Walter-Petrich A, de Margerie-Mellon C, et al
    Long-term outcomes of adult pulmonary Langerhans cell histiocytosis: a prospective cohort.
    Eur Respir J. 2022;59.
    PubMed    
    Abstract available

  159. CERTAIN MC, Baron A, Turpin M, Ebstein N, et al
    Outcomes of cirrhotic patients with pre-capillary pulmonary hypertension and pulmonary vascular resistance between 2 and 3 Wood Units.
    Eur Respir J. 2022 Jun 9. pii: 13993003.00107-2022.
    PubMed    


  160. ALI MK, Schimmel K, Zhao L, Chen CK, et al
    The role of circular RNAs in pulmonary hypertension.
    Eur Respir J. 2022 Jun 9. pii: 13993003.00012-2022.
    PubMed    
    Abstract available

  161. BOUCLY A, Humbert M, Sitbon O
    To be or not to be... treated with initial combination therapy, that is the (PAH) question.
    Eur Respir J. 2022;59.
    PubMed    


  162. HOEPER MM, Pausch C, Grunig E, Staehler G, et al
    Temporal trends in pulmonary arterial hypertension: results from the COMPERA registry.
    Eur Respir J. 2022;59.
    PubMed    
    Abstract available

  163. ZELT JGE, Sugarman J, Weatherald J, Partridge ACR, et al
    Mortality trends in pulmonary arterial hypertension in Canada: a temporal analysis of survival per ESC/ERS guideline era.
    Eur Respir J. 2022;59.
    PubMed    
    Abstract available

  164. VAN DER HAVE O, Westoo C, Ahrne F, Tian X, et al
    Shunt-type plexiform lesions identified in the Sugen5416/hypoxia rat model of pulmonary arterial hypertension using synchrotron-based phase-contrast micro-CT.
    Eur Respir J. 2022;59.
    PubMed    


  165. NAEIJE R, Richter MJ, Rubin LJ
    The physiological basis of pulmonary arterial hypertension.
    Eur Respir J. 2022;59.
    PubMed    
    Abstract available

  166. HUANG S, Vignon P, Mekontso-Dessap A, Tran S, et al
    Echocardiography findings in COVID-19 patients admitted to intensive care units: a multi-national observational study (the ECHO-COVID study).
    Intensive Care Med. 2022 Apr 21. pii: 10.1007/s00134-022-06685.
    PubMed    
    Abstract available

  167. SIEGRIST KK, Woolard AA, Hillenbrand KD, Shah AS, et al
    An Unusual Finding in a Patient Presenting for Pulmonary Thromboendarterectomy: Pulmonary Venous Thrombosis.
    J Cardiothorac Vasc Anesth. 2022;36:2046-2050.
    PubMed    
    Abstract available

  168. TULL CM, Abraham AM, MacArthur JW, Vanneman MW, et al
    Intraoperative Considerations in a Patient on Intravenous Epoprostenol Undergoing Minimally Invasive Cardiac Surgery.
    J Cardiothorac Vasc Anesth. 2022 Apr 22. pii: S1053-0770(22)00282.
    PubMed    


  169. SONG W, Chu S, Yang K, Sun X, et al
    Perinatal Management and Long-Term Follow-up of a Primipara With Severe Pulmonary Arterial Hypertension Associated With Systemic Lupus Erythematosus.
    J Cardiothorac Vasc Anesth. 2022;36.
    PubMed    
    Abstract available

  170. GAIOTTO FA, Bacal F, Steffen SP, Marcondes-Braga FG, et al
    A modified heterotopic heart transplant technique to bridge patients with "fixed" pulmonary hypertension: A case report.
    J Heart Lung Transplant. 2022 May 1. pii: S1053-2498(22)01917.
    PubMed    


  171. WIEDENROTH CB, Deissner H, Adameit MSD, Kriechbaum SD, et al
    Complications of balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension: Impact on the outcome.
    J Heart Lung Transplant. 2022 May 20. pii: S1053-2498(22)01944.
    PubMed    
    Abstract available

  172. AVITABILE CM, Zhang X, Ampah SB, Wang Y, et al
    Factors associated with discontinuation of pulmonary vasodilator therapy in children with bronchopulmonary dysplasia-associated pulmonary hypertension.
    J Perinatol. 2022 Jun 8. pii: 10.1038/s41372-022-01421.
    PubMed    
    Abstract available

  173. CARPENTER RJ, Srdanovic N, Rychlik K, Sen SK, et al
    The association between pulmonary vascular disease and respiratory improvement in infants with type I severe bronchopulmonary dysplasia.
    J Perinatol. 2022 Apr 9. pii: 10.1038/s41372-022-01386.
    PubMed    
    Abstract available

  174. BICHELL DP
    Commentary: The illogic of oversizing donor hearts for pulmonary hypertension.
    J Thorac Cardiovasc Surg. 2022 May 11. pii: S0022-5223(22)00536.
    PubMed    


  175. DUBROCK HM, Del Valle KT, Krowka MJ
    Mending the Model for End-Stage Liver Disease: An in-depth review of the past, present, and future portopulmonary hypertension Model for End-Stage Liver Disease exception.
    Liver Transpl. 2022;28:1224-1230.
    PubMed    
    Abstract available

  176. REZENDE CF, Mancuzo EV, Correa RA
    Heart rate recovery in 1 minute after the 6-minute walk test predicts adverse outcomes in pulmonary arterial hypertension.
    PLoS One. 2022;17:e0268839.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;